Peter Woods

Peter Woods is Programme manager at GB Innomech Ltd (UK).

Articles

The benefits of risk-based analyses during system validation

September 1st 2009

When validating automated systems from third-party providers, using the V model and failure modes effects and criticality analysis (FMECA) early in the process can help.

Latest Updated Articles

Published: October 11th 2024 | Updated: October 18th 2024

Buy, Sell, Hold: Cell and Gene Therapy - Part 1

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 10th 2024 | Updated: September 18th 2024

CPHI Milan Announces 2024 CPHI Pharma Award Finalists

Published: November 22nd 2024 | Updated: November 25th 2024

The Pharmacy Advantage in Direct-to-Patient Clinical Supply

Published: October 28th 2024 | Updated: November 25th 2024

Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development

Operator work on infusion pharmaceutical industry | Image Credit: © xmagics - © xmagics - stock.adobe.com

Published: November 6th 2024 | Updated: November 25th 2024

Automate Aseptic Filling: Closing the System at Full Modularity

Two scientists wearing lab coats and safety glasses analyzing data displayed on a computer screen in a laboratory setting | Image Credit: © NCST Studio - © NCST Studio - stock.adobe.com

Published: November 5th 2024 | Updated: November 25th 2024

Untethered Data: Unifying and Contextualizing Drug Discovery Data

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777